Company: JSDA
Filing Date: 2025-07-03
Form Type: S-1
Source: 0001641172-25-017818
Chunk: 2

Company: JONES SODA CO.
Filing Date: 2025-07-03
Form: S-1
Chunk 2
---
Y 3, 2025

shares of Common Stock

Jones Soda Co.</div>

This is a public offering of shares of common stock, no par value per share (“common stock”), of Jones Soda Co.We are offering $ of shares of our common stock.

Currently, our common stock is quoted on the OTCQB under the symbol “JSDA”, and on the Canadian Securities Exchange (“CSE”) under the symbol “JSDA.” On , 2025, the last reported sale price of our common stock on the OTCQB and CSE was $ and $ per share, respectively. The final public offering price of the shares of common stock in this offering will be determined through negotiation between us and the underwriters in the offering and the recent market price of our common stock used throughout this prospectus may not be indicative of the final offering price.

Currently, there is a limited market for our common stock. We intend to apply to list our common stock on The Nasdaq Capital Market (“Nasdaq”) under the symbol “JBEV”. Accordingly, we expect our common stock to begin trading on Nasdaq on or around the date of this prospectus, at which point our common stock will cease to be traded on the OTCQB. There is no assurance that an active trading market for our common stock will develop or be sustained. If our common stock is not approved for listing on The Nasdaq Capital Market, we will not consummate this offering.

We are a “smaller reporting company,” as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and have elected to take advantage of certain scaled disclosure available to smaller reporting companies. This prospectus is intended to comply with the requirements that apply to an issuer that is a smaller reporting company. See “ Prospectus Summary— Implications of Being a Smaller Reporting Company.”

Investing in our common stock involves risks. Please read “ Risk Factors” beginning on page 11 for factors you should consider before investing in our common stock.

|                                  |     | Per   
 Share |     | Total |
| Public offering price            |     |       |     |       |
| Underwriting discounts and       
 commissions(1)                   |     |       |     |       |
| Proceeds, before expenses, to us |     |       |     |       |

(1) Underwriting discounts and commissions do not include a non-accountable expense allowance equal to 1.0% of the public offering price payable to